medwireNews: The use of a novel, diagnostic test called Xpert (Cepheid Inc, California, USA) is both sensitive and specific in detecting tuberculosis (TB) and rifampicin resistance, report US ...

A study led by Frank Cobelens of the Amsterdam Institute of Global Health and Development, Amsterdam, The Netherlands and colleagues reports on the cost-effectiveness of implementing the Xpert MTB/RIF ...

In an HIV-positive population, the Xpert MTB/RIF Ultra assay detected tuberculous meningitis with higher sensitivity than the older Xpert assay and a mycobacterial growth indicator tube culture, ...

Xpert assay provided better sensitivity for the diagnosis of pulmonary tuberculosis in children when compared with microscopy, and its scale-up will improve access to tuberculosis diagnostics for ...

Hope brightens for tuberculosis diagnosis and treatment in Nigeria as a 16-Module Genexpert Machine is launched in Lagos. This will increase the testing and diagnosis capacity of TB, allowing patients ...

Two research studies in this week's PLoS Medicine suggest that a new automated DNA test for tuberculosis (Xpert MTB/RIF), which can detect TB within 2 hours and has been endorsed by the World Health ...

Microbiological confirmation of childhood tuberculosis is rare because of the difficulty of collection of specimens, low sensitivity of smear microscopy, and poor access to culture. A new study aimed ...

Background: The identification of non-tuberculosis (TB) mycobacterial (NTM) infection remains a significant challenge. This study aims to investigate the diagnostic value of multicolour nested ...

The Xpert MTB/RIF (Cepheid) test improved tuberculosis (TB) diagnosis and reduced time to treatment, but not long-term TB-related morbidity, according to the results of a multicenter, randomized, ...

Tuberculosis (TB) causes more deaths globally than any other infectious disease and is a top 10 cause of death worldwide. Globally in 2017, of the estimated 10 million people with TB, 3.6 million were ...